Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (25)
Magdalena Malm, Fredrik Y. Frejd, Stefan Ståhl & John Löfblom. (2016) Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds. mAbs 8:7, pages 1195-1209.
Read now
Read now
Zhen Zhao, Rui Li, Sha Sha, Qiong Wang, Weidong Mao & Tao Liu. (2014) Targeting HER3 with miR-450b-3p suppresses breast cancer cells proliferation. Cancer Biology & Therapy 15:10, pages 1404-1412.
Read now
Read now
Monica Dandona Desai, Bikramajit Singh Saroya & Albert Craig Lockhart. (2013) Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers. Expert Opinion on Investigational Drugs 22:3, pages 341-356.
Read now
Read now
Rita Nahta. (2012) New developments in the treatment of HER2-positive breast cancer. Breast Cancer: Targets and Therapy 4, pages 53-64.
Read now
Read now
Bo Chen, Rui Mao, Hongjie Wang & Jin-Xiong She. (2010) Cell line and drug-dependent effect of ERBB3 on cancer cell proliferation, chemosensitivity, and multidrug actions. International Journal of High Throughput Screening 1, pages 49-55.
Read now
Read now
Angelos K Koutras & T R Jeffry Evans. (2008) The epidermal growth factor receptor family in breast cancer. OncoTargets and Therapy 1, pages 5-19.
Read now
Read now
Jonas Cicenas$suffix/text()$suffix/text(). (2007) The potential role of the EGFR/ERBB2 heterodimer in breast cancer. Expert Opinion on Therapeutic Patents 17:6, pages 607-616.
Read now
Read now
H. Peter Rodemann, Klaus Dittmann & Mahmoud Toulany. (2007) Radiation-induced EGFR-signaling and control of DNA-damage repair. International Journal of Radiation Biology 83:11-12, pages 781-791.
Read now
Read now
Susanne J Rogers, Carol Box, Kevin J Harrington, Chris Nutting, Peter Rhys-Evans & Suzanne A Eccles. (2005) The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck. Expert Opinion on Therapeutic Targets 9:4, pages 769-790.
Read now
Read now
Lindsay K. MacDougall, Mary Elizabeth Gagou, Sally J. Leevers, Ernst Hafen & Michael D. Waterfield. (2004) Targeted Expression of the Class II Phosphoinositide 3-Kinase in Drosophila melanogaster Reveals Lipid Kinase-Dependent Effects on Patterning and Interactions with Receptor Signaling Pathways. Molecular and Cellular Biology 24:2, pages 796-808.
Read now
Read now
Eran R. Andrechek, William R. Hardy, Adele A. Girgis-Gabardo, Robert L. S. Perry, Richard Butler, Frank L. Graham, Ronald C. Kahn, Michael A. Rudnicki & William J. Muller. (2002) ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival. Molecular and Cellular Biology 22:13, pages 4714-4722.
Read now
Read now
Carolyn I. Sartor, Hong Zhou, Ewa Kozlowska, Katherine Guttridge, Evelyn Kawata, Laura Caskey, Jennifer Harrelson, Nancy Hynes, Stephen Ethier, Benjamin Calvo & H. Shelton Earp$suffix/text()$suffix/text(). (2001) HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells. Molecular and Cellular Biology 21:13, pages 4265-4275.
Read now
Read now
Alexandre Arcaro, Marketa J. Zvelebil, Christian Wallasch, Axel Ullrich, Michael D. Waterfield & Jan Domin. (2000) Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors. Molecular and Cellular Biology 20:11, pages 3817-3830.
Read now
Read now
Gerard A. Rodrigues, Marco Falasca, Zhongtao Zhang, Siew Hwa Ong & Joseph Schlessinger. (2000) A Novel Positive Feedback Loop Mediated by the Docking Protein Gab1 and Phosphatidylinositol 3-Kinase in Epidermal Growth Factor Receptor Signaling. Molecular and Cellular Biology 20:4, pages 1448-1459.
Read now
Read now
Senthil K. Muthuswamy, Michael Gilman & Joan S. Brugge. (1999) Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers. Molecular and Cellular Biology 19:10, pages 6845-6857.
Read now
Read now
D. G. Todd, R. B. Mikkelsen, W. K. Rorrer, K. Valerie & R. K. Schmidt-Ullrich. (1999) Ionizing Radiation Stimulates Existing Signal Transduction Pathways Involving the Activation of Epidermal Growth Factor Receptor and Erbb-3, and Changes of Intracellular Calcium in A431 Human Squamous Carcinoma Cells. Journal of Receptors and Signal Transduction 19:6, pages 885-908.
Read now
Read now
Roger J. Daly. (1999) Take Your Partners, Please — Signal Diversification by the erbB Family of Receptor Tyrosine Kinases. Growth Factors 16:4, pages 255-263.
Read now
Read now
Marc A. Webster, John N. Hutchinson, Michael J. Rauh, Senthil K. Muthuswamy, Martina Anton, Christopher G. Tortorice, Robert D. Cardiff, Frank L. Graham, John A. Hassell & William J. Muller. (1998) Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis. Molecular and Cellular Biology 18:4, pages 2344-2359.
Read now
Read now
George Kulik, Anke Klippel & Michael J. Weber. (1997) Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt. Molecular and Cellular Biology 17:3, pages 1595-1606.
Read now
Read now
Eldad Tzahar, Hadassa Waterman, Xiomei Chen, Gil Levkowitz, Devarajan Karunagaran, Sara Lavi, Barry J. Ratzkin & Yosef Yarden. (1996) A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor. Molecular and Cellular Biology 16:10, pages 5276-5287.
Read now
Read now
Lei Ling & Hsing-Jien Kung. (1995) Mitogenic Signals and Transforming Potential of Nyk, a Newly Identified Neural Cell Adhesion Molecule-Related Receptor Tyrosine Kinase. Molecular and Cellular Biology 15:12, pages 6582-6592.
Read now
Read now
Roger R. Beerli, Diana Graus-Porta, Kathie Woods-Cook, Xiaomei Chen, Yosef Yarden & Nancy E. Hynes. (1995) Neu Differentiation Factor Activation of ErbB-3 and ErbB-4 Is Cell Specific and Displays a Differential Requirement for ErbB-2. Molecular and Cellular Biology 15:12, pages 6496-6505.
Read now
Read now
David J. Riese$suffix/text()$suffix/text(), Tom M. van Raaij, Gregory D. Plowman, Glenn C. Andrews & David F. Stern. (1995) The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family. Molecular and Cellular Biology 15:10, pages 5770-5776.
Read now
Read now
Diana Graus-Porta, Roger R. Beerli & Nancy E. Hynes. (1995) Single-Chain Antibody-Mediated Intracellular Retention of ErbB-2 Impairs Neu Differentiation Factor and Epidermal Growth Factor Signaling. Molecular and Cellular Biology 15:3, pages 1182-1191.
Read now
Read now
Articles from other publishers (28)
Christopher Y.C. Chow, Erich Ferdiansyah Lie, Cheng-Hsun Wu & Louis W.C. Chow. (2022) Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers. Frontiers in Oncology 12.
Crossref
Crossref
Nischal Koirala, Nandini Dey, Jennifer Aske & Pradip De. (2022) Targeting Cell Cycle Progression in HER2+ Breast Cancer: An Emerging Treatment Opportunity. International Journal of Molecular Sciences 23:12, pages 6547.
Crossref
Crossref
Aglaia Skolariki, Jamie D’Costa, Martin Little & Simon Lord. (2022) Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic. Exploration of Targeted Anti-tumor Therapy, pages 172-199.
Crossref
Crossref
Michel M. Ouellette, Sumin Zhou & Ying Yan. (2022) Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. Diagnostics 12:3, pages 656.
Crossref
Crossref
Xinping Chen, Weihua Xu, Zhichao Ma, Juan Zhu, Junjie Hu, Xiaojuan Li & Shengmiao Fu. (2021) Circ_0000215 Exerts Oncogenic Function in Nasopharyngeal Carcinoma by Targeting miR-512-5p. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Tetsu HayashidaFumiyuki TakahashiNaokazu ChibaElena Brachtel, Motomi TakahashiNadia Godin-HeymannKenneth W. GrossMaria d. M. Vivanco, Vasuki Wijendran, Toshihiro ShiodaDennis Sgroi, Patricia K. DonahoeShyamala Maheswaran. (2009)
HOXB9
, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis
. Proceedings of the National Academy of Sciences 107:3, pages 1100-1105.
Crossref
Crossref
Natalia Jura, Yibing Shan, Xiaoxian Cao, David E. Shaw & John Kuriyan. (2009) Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proceedings of the National Academy of Sciences 106:51, pages 21608-21613.
Crossref
Crossref
Thomas Bachleitner-Hofmann, Mark Y. Sun, Chin-Tung Chen, Laura Tang, Lin Song, Zhaoshi Zeng, Manish Shah, James G. Christensen, Neal Rosen, David B. Solit & Martin R. Weiser. (2008) HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells. Molecular Cancer Therapeutics 7:11, pages 3499-3508.
Crossref
Crossref
S. Michael Rothenberg, Jeffrey A. Engelman, Sheila LeDavid J. RieseIIII, Daniel A. Haber & Jeffrey Settleman. (2008) Modeling oncogene addiction using RNA interference. Proceedings of the National Academy of Sciences 105:34, pages 12480-12484.
Crossref
Crossref
Fumiyuki Yamasaki, Mary J. Johansen, Dongwei Zhang, Savitri Krishnamurthy, Edward Felix, Chandra Bartholomeusz, Richard J. Aguilar, Kaoru Kurisu, Gordon B. Mills, Gabriel N. Hortobagyi & Naoto T. Ueno. (2007) Acquired Resistance to Erlotinib in A-431 Epidermoid Cancer Cells Requires Down-regulation of MMAC1/PTEN and Up-regulation of Phosphorylated Akt. Cancer Research 67:12, pages 5779-5788.
Crossref
Crossref
Christopher D. Coldren, Barbara A. Helfrich, Samir E. Witta, Michio Sugita, Razvan Lapadat, Chan Zeng, Anna Barón, Wilbur A. Franklin, Fred R. Hirsch, Mark W. Geraci & Paul A. BunnJr.Jr.. (2006) Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non–Small Cell Lung Cancer Cell Lines. Molecular Cancer Research 4:8, pages 521-528.
Crossref
Crossref
Elizabeth Buck, Alexandra Eyzaguirre, John D. Haley, Neil W. Gibson, Pablo Cagnoni & Kenneth K. Iwata. (2006) Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity. Molecular Cancer Therapeutics 5:8, pages 2051-2059.
Crossref
Crossref
Akira Hirata, Fumihito Hosoi, Miho Miyagawa, Shu-ichi Ueda, Seiji Naito, Teruhiko Fujii, Michihiko Kuwano & Mayumi Ono. (2005) HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells. Cancer Research 65:10, pages 4253-4260.
Crossref
Crossref
Gunamani Sithanandam, Laura W Fornwald, Janet Fields & Lucy M Anderson. (2005) Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene 24:11, pages 1847-1859.
Crossref
Crossref
Jeffrey A. Engelman, Pasi A. Jänne, Craig Mermel, Joseph Pearlberg, Toru Mukohara, Christina Fleet, Karen Cichowski, Bruce E. Johnson & Lewis C. Cantley. (2005) ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proceedings of the National Academy of Sciences 102:10, pages 3788-3793.
Crossref
Crossref
Wenle Xia, Lei-Hua Liu, Peter Ho & Neil L Spector. (2004) Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016. Oncogene 23:3, pages 646-653.
Crossref
Crossref
Gerald E Stoica, Thomas F Franke, Maria Moroni, Susette Mueller, Elisha Morgan, Mary C Iann, Abigail D Winder, Ronald Reiter, Anton Wellstein, Mary Beth Martin & Adriana Stoica. (2003) Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:39, pages 7998-8011.
Crossref
Crossref
Denise K Walters, Jena D French, Bonnie K Arendt & Diane F Jelinek. (2003) Atypical expression of ErbB3 in myeloma cells: cross-talk between ErbB3 and the interferon-α signaling complex. Oncogene 22:23, pages 3598-3607.
Crossref
Crossref
Gerald E Stoica, Thomas F Franke, Anton Wellstein, Elisha Morgan, Frank Czubayko, Heinz-Joachim List, Ronald Reiter, Mary Beth Martin & Adriana Stoica. (2003) Heregulin-β1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway. Oncogene 22:14, pages 2073-2087.
Crossref
Crossref
Michimoto Kobayashi, Akihiro Iwamatsu, Azusa Shinohara-Kanda, Sayoko Ihara & Yasuhisa Fukui. (2003) Activation of ErbB3–PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. Oncogene 22:9, pages 1294-1301.
Crossref
Crossref
Xiao-Bo Qiu & Alfred L. Goldberg. (2002) Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proceedings of the National Academy of Sciences 99:23, pages 14843-14848.
Crossref
Crossref
Richard M Neve, Thomas Holbro & Nancy E Hynes. (2002) Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells. Oncogene 21:29, pages 4567-4576.
Crossref
Crossref
Joseph N Contessa, Jaime Hampton, Guido Lammering, Ross B Mikkelsen, Paul Dent, Kristoffer Valerie & Rupert K Schmidt-Ullrich. (2002) Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene 21:25, pages 4032-4041.
Crossref
Crossref
Frank A Suprynowicz, Astrid Baege, Iruvanti Sunitha & Richard Schlegel. (2002) c-Src Activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation. Oncogene 21:11, pages 1695-1706.
Crossref
Crossref
Allison P Belsches-Jablonski, Jacqueline S Biscardi, Dena R Peavy, David A Tice, Davis A Romney & Sarah J Parsons. (2001) Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene 20:12, pages 1465-1475.
Crossref
Crossref
T Kamalati, H E Jolin, M J Fry & M R Crompton. (2000) Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19:48, pages 5471-5476.
Crossref
Crossref
Simon Ekman, Eva Rupp Thuresson, Carl-Henrik Heldin & Lars Rönnstrand. (1999) Increased mitogenicity of an αβ heterodimeric PDGF receptor complex correlates with lack of RasGAP binding. Oncogene 18:15, pages 2481-2488.
Crossref
Crossref
Marina Holgado-Madruga, David K. Moscatello, David R. Emlet, Rebekka Dieterich & Albert J. Wong. (1997) Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proceedings of the National Academy of Sciences 94:23, pages 12419-12424.
Crossref
Crossref